Rigetti Computing COO David Rivas sells $151,734 in stock

Rigetti Computing shares slid 8.7% to $16.07 after Q2 2026 results met Wall Street expectations but highlighted worsening losses: revenue rose 183% to $5.13M while adjusted EPS was -$0.05. The CFO/COO-related insider action also drew attention—David Rivas sold 9,038 shares for $151,734 at a weighted avg. $16.7885 to cover tax withholding tied to RSU settlement. Investors remain cautious given expanding losses and higher spending despite ongoing progress toward its Novera quantum hardware and long-term “quantum advantage” goals.

Analysis

This is less about the insider transaction than about the market starting to price RGTI as a funding story, not a technology story. When a pre-scale name is growing revenue off a tiny base but still expanding losses, the equity behaves like a long-duration call option whose value is extremely sensitive to discount rates, sentiment, and the probability of additional dilution over the next 6-18 months. That means the stock can rerate down even on “acceptable” prints if investors conclude commercialization is slipping relative to spending.

The first-order loser is RGTI holders, but the second-order spillover is to the entire quantum basket: a weak tape in RGTI can compress multiples for QUBT and any adjacent speculative compute names because the market will treat one weak execution point as evidence that the category still lacks repeatable demand. In the near term, this is also a liquidity trade: if broader risk appetite deteriorates, high-beta, low-liquidity names get sold mechanically regardless of company-specific disclosures.

The contrarian angle is that the market may be underweighting optionality from on-premise hardware sales if they can become a recurring commercial wedge. What would falsify the bearish setup is not another “in-line” quarter, but evidence of sequential revenue acceleration, slower operating expense growth, and a clearer runway without equity issuance. If those metrics do not improve over the next 1-2 quarters, multiple compression should continue even if headline revenue growth remains strong.

Key Decisions for Investors

• Short RGTI on any relief rally back toward the pre-breakdown area; use a 1-3 month horizon and keep the thesis live only while sequential revenue does not outpace burn. Initial downside objective: last week’s low, then lower if the next update shows continued opex expansion.
• If options liquidity is acceptable, buy a 30-60 day RGTI put spread to express downside with defined risk; this is cleaner than outright shorting a volatile small-cap where borrow can tighten quickly.
• Relative-value pair: short RGTI / long IONQ as a quality-versus-story trade in quantum, expressing the view that RGTI’s smaller commercial base is more exposed to valuation compression if the sector de-rates.
• Set a stop-loss/falsifier on RGTI if management shows two consecutive quarters of sequential revenue growth with flat-to-down operating losses; that would argue the market is over-discounting commercialization.